Researchers discovered that a specific calcium transporter could be a potential new target for drug treatments options aiming to prevent the spread of malaria.
A recent study has found that dengue fever, nicknamed “bone breaking fever” for the aches that it can cause, occurs three times as often as was previously thought.
A new study suggests that in order to tackle malaria, perhaps a different approach toward developing drugs and vaccines for the disease may be helpful. The research, by scientists from the University of Edinburgh, into the malaria causing parasites (males and females) suggests that treatment would be more effective if it is targeted at female forms of the parasite. The research revealed that male parasites are more capable of adapting to new surroundings when compared to female parasites. Thus, after a mosquito bite, once the blood stream is affected with malaria virus, the male mosquitoes are able to able quickly reach to the repeated attacks by the immune system and are likely to be harder to treat with drugs and vaccines, Medical Xpress reported.
Until recently, patients suffering from common ophthalmic ailments such as retinal disorders, glaucoma, and dry eye have largely been prescribed anti-inflammatory, anti-infective, anti-glaucoma, and anti-allergy agents, in addition to off-label steroidal medications, and warm compresses.